KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Share-based Compensation: 2009-2024

Historic Share-based Compensation for Chemed (CHE) over the last 16 years, with FY2024 value amounting to $32.0 million.

  • Chemed's Share-based Compensation rose 48.03% to $6.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.5 million, marking a year-over-year increase of 153.83%. This contributed to the annual value of $32.0 million for FY2024, which is 648.56% up from last year.
  • As of FY2024, Chemed's Share-based Compensation stood at $32.0 million, which was up 648.56% from $30.1 million recorded in FY2023.
  • Over the past 5 years, Chemed's Share-based Compensation peaked at $32.0 million during FY2024, and registered a low of $18.4 million during FY2020.
  • Over the past 5 years, Chemed's median Share-based Compensation value was $26.3 million (recorded in 2022), while the average stood at $25.9 million.
  • Its Share-based Compensation has fluctuated over the past 5 years, first skyrocketed by 2421.28% in 2020, then soared by 648.56% in 2024.
  • Over the past 5 years, Chemed's Share-based Compensation (Annual) stood at $18.4 million in 2020, then increased by 22.15% to $22.5 million in 2021, then increased by 16.67% to $26.3 million in 2022, then increased by 14.58% to $30.1 million in 2023, then increased by 6.49% to $32.0 million in 2024.
  • Its Share-based Compensation was $32.0 million in FY2024, compared to $30.1 million in FY2023 and $26.3 million in FY2022.